<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Mon, 18 May 2026 06:26:49 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/hemophilla/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Global Acquired Hemophilia Treatment Market Is Expected To Reach USD 2,474.7 Mn By 2023: Credence Research]]></title><description><![CDATA[The latest market report published by Credence Research, Inc. “Global Acquired Hemophilia Treatment Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2023,” the acquired]]></description><link>http://direct.ecency.com/acquired/@david23/global-acquired-hemophilia-treatment-market-is-expected-to-reach-usd-2-474-7-mn-by-2023-credence-research</link><guid isPermaLink="true">http://direct.ecency.com/acquired/@david23/global-acquired-hemophilia-treatment-market-is-expected-to-reach-usd-2-474-7-mn-by-2023-credence-research</guid><category><![CDATA[acquired]]></category><dc:creator><![CDATA[david23]]></dc:creator><pubDate>Mon, 06 Nov 2017 10:16:30 GMT</pubDate></item></channel></rss>